An efficient, organocatalytic, highly enantioselective, conjugate addition reaction of nitromethane with a,b-unsaturated aldehydes has been developed. The process serves as the key step for a practical 3-step synthesis of chiral baclofen, an antispastic drug.Keywords: asymmetric catalysis; asymmetric synthesis; C À C bond formation; Michael addition; organic catalysisThe synthesis of natural products and therapeutics has served as a principal driving force for discovering new synthetic methods. On the other hand, the synthetic value of useful synthetic methods can be quickly established in the context of the efficient preparation of biologically important pharmaceuticals and natural products. Baclofen (1; Figure 1), a potent GABA B receptor agonist, is used for the treatment of spinal cord injury-induced spasm.[1] Despite the fact that the racemic form of baclofen is used in clinical practice, [1a] the (R) enantiomer is the essential active chemical entity and its (S) form is inactive. Accordingly, a great deal of effort has been directed to the synthesis of chiral (R)-baclofen. These methodologies rely on the use of chiral precursors, [2] chiral auxiliaries, [3] and chemical [4] and enzymatic [5] resolutions. Atom-economic asymmetric catalytic strategies including organometallic [6] and organocatalytic [7] systems also have been developed. However, these approaches suffer from long synthetic sequences and the use of not readily available chemicals, thus limiting their practical application for a large-scale synthesis. The synthetic significance is further underscored by the utilization of baclofen as a lead compound for the design of GABA agonists and antagonists to seek new therapeutic agents targeting on the central nervous system (CNS). [1a,8] The analogues of baclofen can potentially be developed for the treatment of a variety of diseases including epilepsy, Huntingtons and Parkinsons diseases, and other psychiatric disorders, such as anxiety and pain. [1a,8] As a consequence, the development of general, efficient synthetic strategies enabling a facile approach to chiral baclofen and its analogues is of considerable significance from the standpoint of the medicinal and organic chemistry. Driven by the lack of such a facile access to this class of compounds, in this communication we disclose a remarkably efficient and practical route for the highly enantioselective synthesis of optically active baclofen in 3 steps from the readily available simple achiral molecules a,b-unsaturated aldehydes and nitroalkanes. The key step relies on a highly efficient organocatalytic enantioselective conjugate addition reaction of nitromethane with a,b-unsaturated aldehydes, which we have successfully developed in the study. This efficient synthetic strategy can be further explored for the rapid preparation of new chiral baclofen analogues in drug discovery.Our synthetic strategy towards chiral baclofen (1) is described in Scheme 1. We hypothesized that compound 1 could be constructed from chiral g-nitro aldehyde 2...